HFS
PFE icon

HL Financial Services’s Pfizer PFE Stock Holding History

HL Financial Services’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$138M Buy
3,427,958
+74,117
+2% +$2.97M 2.12% 10
2018
Q4 		$139M Buy
3,353,841
+23,168
+0.7% +$962K 2.43% 8
2018
Q3 		$139M Buy
3,330,673
+28,730
+0.9% +$1.11M 2.15% 12
2018
Q2 		$114M Sell
3,301,943
-52,506
-2% -$1.79M 1.97% 14
2018
Q1 		$113M Buy
3,354,449
+38,957
+1% +$1.34M 2% 14
2017
Q4 		$114M Sell
3,315,492
-59,361
-2% -$2.02M 2.21% 12
2017
Q3 		$114M Sell
3,374,853
-22,173
-0.7% -$713K 2.21% 13
2017
Q2 		$108M Buy
3,397,026
+37,674
+1% +$1.19M 2.16% 14
2017
Q1 		$109M Buy
3,359,352
+113,640
+4% +$3.58M 2.24% 11
2016
Q4 		$100M Buy
3,245,712
+139,066
+4% +$4.25M 2.15% 13
2016
Q3 		$99.8M Buy
3,106,646
+65,383
+2% +$2.19M 2.33% 10
2016
Q2 		$102M Buy
3,041,263
+73,426
+2% +$2.34M 2.4% 9
2016
Q1 		$83.5M Buy
2,967,837
+120,851
+4% +$3.45M 2.03% 15
2015
Q4 		$87.2M Buy
2,846,986
+87,533
+3% +$2.75M 2.23% 12
2015
Q3 		$82.2M Buy
2,759,453
+21,324
+0.8% +$684K 2.32% 11
2015
Q2 		$87.1M Buy
2,738,129
+42,769
+2% +$1.39M 2.31% 11
2015
Q1 		$89M Buy
2,695,360
+46,864
+2% +$1.49M 2.39% 8
2014
Q4 		$78.3M Buy
2,648,496
+35,104
+1% +$1.01M 2.14% 13
2014
Q3 		$73.3M Buy
2,613,392
+37,130
+1% +$1.04M 2.13% 12
2014
Q2 		$72.5M Sell
2,576,262
-6,590
-0.3% -$188K 2.11% 12
2014
Q1 		$78.7M Buy
2,582,852
+7,398
+0.3% +$221K 2.37% 9
2013
Q4 		$74.8M Buy
2,575,454
+140,737
+6% +$4.1M 2.27% 11
2013
Q3 		$66.4M Buy
2,434,717
+49,222
+2% +$1.34M 2.32% 9
2013
Q2 		$63.4M Buy
+2,385,495
New +$65.9M 2.33% 9

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HL Financial Services's PFE Position: Q1 2019 in Review

HL Financial Services increased its Pfizer (PFE) stake by 2.2% in Q1 2019, buying an estimated $2.97M and bringing the position to 3,427,958 shares worth $138M. The position accounts for 2.12% of the portfolio, ranked #10.

HL Financial Services first reported a position in PFE in Q2 2013 and has held it in 24 quarters since. The position peaked at $139M in Q3 2018. 2,391 funds tracked by Wall St. Rank hold PFE as of Q1 2019.

  • HL Financial Services held 3,427,958 shares of Pfizer worth $138M as of Q1 2019.
  • HL Financial Services bought 74,117 Pfizer shares in Q1 2019, an estimated $2.97M.
  • Pfizer made up 2.12% of HL Financial Services's portfolio in Q1 2019, its #10 holding.
  • HL Financial Services first reported a position in Pfizer in Q2 2013 and has held it in 24 quarters since.
  • HL Financial Services's Pfizer position peaked at $139M in Q3 2018.
  • 2,391 funds tracked by Wall St. Rank held Pfizer as of Q1 2019.

Based on HL Financial Services's 13F filing for Q1 2019, filed 1 May 2019.